Cresco Labs (CRLBF) Operating Expenses (2020 - 2026)

Cresco Labs has reported Operating Expenses for 7 years, with the latest figure at $64.3 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 1.18% year-over-year to $64.3 million; the trailing twelve-month figure through Mar 2026 stood at $351.8 million (up 35.74% YoY), and the FY2025 full-year result was $352.6 million, up 37.09% from the prior year.
• Operating Expenses for Q1 2026 stood at $64.3 million, down from $158.9 million in the prior quarter.
• The five-year high for Operating Expenses was $231.2 million in Q4 2022, with the low at $61.5 million in Q3 2025.
• Historically, Operating Expenses has averaged $95.0 million across 5 years, with a median of $69.0 million in 2023.
• Annual changes were most pronounced in 2022 — Operating Expenses sank 77.74% — and 2025, when it surged 145.85%.
• Cresco Labs' Operating Expenses stood at $231.2 million in 2022, then plunged by 70.13% to $69.0 million in 2023, then slipped by 6.41% to $64.6 million in 2024, then surged by 145.85% to $158.9 million in 2025, then slumped by 59.54% to $64.3 million in 2026.
• The last three Operating Expenses figures came in at $64.3 million (Q1 2026), $158.9 million (Q4 2025), and $61.5 million (Q3 2025), per Business Quant data.